Burkina Faso vs Sierra Leone: Hepatitis B surface antigen (HBsAg) prevalence
Burkina Faso
0.7%
in 2024
Sierra Leone
0.7%
in 2024
Burkina Faso rank
43rd
Sierra Leone rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Burkina Faso
- Sierra Leone
How they compare
Burkina Faso currently reports 0.7% against 0.7% in Sierra Leone, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Sierra Leone ahead.
Burkina Faso ranks 43rd and Sierra Leone ranks 43rd of 194 countries.
Sierra Leone has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 1.3% | 0.3% | Sierra Leone |
| 2020s | 0.8% | 0.8% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Burkina Faso or Sierra Leone?
- Burkina Faso, at 0.7% against 0.7% in Sierra Leone as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Burkina Faso and Sierra Leone?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Sierra Leone?
- 10 years are reported by both, from 2015 to 2024.
- How do Burkina Faso and Sierra Leone rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Burkina Faso ranks 43rd and Sierra Leone ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.